| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C0013203> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C0017431> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C0019693> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C3661526> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C4505456> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34922614_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Medicine, Division of Allergy & Infectious Diseases, Center for Emerging & Re-Emerging Infectious Diseases, University of Washington, Seattle, WA, USA. raugid@uw.edu.\', \'Service des Maladies Infectieuses et Tropicales, Ibrahima Diop Mar, Centre Hospitalier National Universitaire de Fann, Universite Cheikh Anta Diop de Dakar, Dakar, Senegal.\', \'Centre de Sante de Ziguinchor, Ziguinchor, Senegal.\', \'Department of Medicine, Division of Allergy & Infectious Diseases, Center for Emerging & Re-Emerging Infectious Diseases, University of Washington, Seattle, WA, USA.\', \'Department of Epidemiology, University of Washington, Seattle, WA, USA.\', \'Department of Global Health, University of Washington, Seattle, WA, USA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Cisse_Ousseynou> <https://research.tib.eu/covid-19/entity/Diallo_Khardiata> <https://research.tib.eu/covid-19/entity/Diallo_Mouhamadou_Ba%C3%AFla> <https://research.tib.eu/covid-19/entity/Diatta_Jean_Philippe> <https://research.tib.eu/covid-19/entity/Diaw_Binetou> <https://research.tib.eu/covid-19/entity/Faye_Dominique> <https://research.tib.eu/covid-19/entity/Faye_Khadim> <https://research.tib.eu/covid-19/entity/Gottlieb_Geoffrey_S> <https://research.tib.eu/covid-19/entity/Hawes_Stephen_E> <https://research.tib.eu/covid-19/entity/Malomar_Jean_Jacques> <https://research.tib.eu/covid-19/entity/Raugi_Dana_N> <https://research.tib.eu/covid-19/entity/Sall_El_Hadji_Ibrahima> <https://research.tib.eu/covid-19/entity/Sall_Fatima> <https://research.tib.eu/covid-19/entity/Sambou_Jacques> <https://research.tib.eu/covid-19/entity/Seydi_Moussa> <https://research.tib.eu/covid-19/entity/Smith_Robert_A>
?:doi	<https://research.tib.eu/covid-19/entity/10.1186/s13063-021-05902-5>
?:doi	10.1186/s13063-021-05902-5
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Clinical_Trial> <https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Trials
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34922614>
?:pmid	<https://research.tib.eu/covid-19/entity/34922614>
?:pmid	34922614
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.291
?:rankingScore_hIndex	57
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0679646_LOCATION_OF_C3811119> <https://research.tib.eu/covid-19/entity/C3811119_ASSOCIATED_WITH_C0035258> <https://research.tib.eu/covid-19/entity/C3811119_PART_OF_C0001675>
?:title	Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Department of Medicine, Division of Allergy & Infectious Diseases, Center for Emerging & Re-Emerging Infectious Diseases, University of Washington, Seattle, WA, USA. raugid@uw.edu.\', \'Service des Maladies Infectieuses et Tropicales, Ibrahima Diop Mar, Centre Hospitalier National Universitaire de Fann, Universite Cheikh Anta Diop de Dakar, Dakar, Senegal.\', \'Centre de Sante de Ziguinchor, Ziguinchor, Senegal.\', \'Department of Medicine, Division of Allergy & Infectious Diseases, Center for Emerging & Re-Emerging Infectious Diseases, University of Washington, Seattle, WA, USA.\', \'Department of Epidemiology, University of Washington, Seattle, WA, USA.\', \'Department of Global Health, University of Washington, Seattle, WA, USA.\']

?:citedBy

-1

?:creator

?:doi

<https://research.tib.eu/covid-19/entity/10.1186/s13063-021-05902-5>

?:doi

10.1186/s13063-021-05902-5

?:hasPublicationType

?:journal

Trials

is ?:pmid of

<https://research.tib.eu/covid-19/entity/34922614>

?:pmid

<https://research.tib.eu/covid-19/entity/34922614>

?:pmid

34922614

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

1.291

?:rankingScore_hIndex

is ?:relation_isRelatedTo_publication of

?:title

Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal.

?:type

?:year

2021

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34922614>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34922614>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata